Search

Search Constraints

You searched for: Author/Creator Hansen, Torben Frøstrup

Search Results

1. A 3-weekly schedule of irinotecan and panitumumab for wild-type KRAS metastatic colorectal cancer. (April 2014)

2. A novel mesenchymal‐associated transcriptomic signature for risk‐stratification and therapeutic response prediction in colorectal cancer. Issue 11 (13th July 2020)

5. Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients. Issue 6 (June 2022)

6. OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol. (2nd September 2022)

9. Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. Issue 1 (21st February 2021)